CLINICAL_TRIALS trial_result · 2012-01-18

Clinical Trial Update: Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study [Phase 3]

Phase 3 clinical trial update for rheumatoid arthritis investigating moderate to low disease activity; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: UCB Pharma | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2012-01-18